Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Avanir Pharmaceuticals (AVNR) is +79% early on after saying a reformulated version of its Zenvia...

  • Tuesday, August 11, 2009, 9:33 AM ET
    Avanir Pharmaceuticals (AVNR) is +79% early on after saying a reformulated version of its Zenvia drug reduced the effects of pseudobulbar affect (PBA)), a condition in which patients cannot control outbursts of crying or laughing that affects two million Americans.
Track new comments on this story

This news story has 1 comment:

  •  
    Perfect medicine to control our boom/bust economy. All the gloom & doom bears, and happy-days-are-here-again bulls should regulary pop one
    11 Aug 2009, 09:43 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Articles
More Latest Articles »